Disc Medicine, Inc. (IRON)

Disc Medicine Stock Forecast

Stock Price Forecast

The 12 analysts that cover Disc Medicine stock have a consensus rating of "Strong Buy" and an average price target of $108.83, which forecasts a 16.71% increase in the stock price over the next year. The lowest target is $75 and the highest is $153.

Price Target: $108.83 (+16.71%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$75	$108.83	$114	$153
Change	-19.57%	+16.71%	+22.25%	+64.08%

Analyst Ratings

The average analyst rating for Disc Medicine stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jun '25	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25
Strong Buy	4	5	5	5	5	6
Buy	7	8	7	7	7	6
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	13	12	12	12	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Danielle Brill Truist Securities	Truist Securities	Strong Buy Maintains $86 → $114	Strong Buy	Maintains	$86 → $114	+22.25%	Nov 10, 2025
Stephen Willey Stifel	Stifel	Strong Buy Initiates $125	Strong Buy	Initiates	$125	+34.05%	Nov 3, 2025
Sean Laaman Morgan Stanley	Morgan Stanley	Buy Maintains $90 → $115	Buy	Maintains	$90 → $115	+23.32%	Oct 30, 2025
Martin Auster Raymond James	Raymond James	Strong Buy Maintains $89 → $108	Strong Buy	Maintains	$89 → $108	+15.82%	Oct 17, 2025
Kristen Kluska Cantor Fitzgerald	Cantor Fitzgerald	Buy Maintains $132 → $153	Buy	Maintains	$132 → $153	+64.08%	Oct 17, 2025

More Analyst Ratings

Financial Forecast

• Revenue This Year:
  n/a
• Revenue Next Year:
  33.56M
• EPS This Year:
  -5.72

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-	-	33.56M
Revenue Growth	-	-	-	-	-	-	-
EPS	-3.02	-40.95	-45.05	-3.42	-3.96	-5.72	-6.13
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	14	13

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	n/a	73.0M
Avg	n/a	33.6M
Low	n/a	11.0M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	-4.84	-5.21
Avg	-5.72	-6.13
Low	-5.95	-7.40

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.